NITRIC OXIDE

NITRIC OXIDE was reported 4627 times

NITRIC OXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TIDAL VOLUME ABNORMAL 2 0.5000
1 ALVEOLAR CAPILLARY DYSPLASIA 12 0.3750
2 DEVICE USER INTERFACE ISSUE 13 0.3611
3 ATRIAL PRESSURE 1 0.3333
4 BLEPHAROPHIMOSIS CONGENITAL 1 0.3333
5 VITAMIN B1 INCREASED 15 0.3191
6 UNDERSENSING 23 0.2738
7 PULMONARY BULLAE RUPTURE 2 0.2500
8 CARDIAC OUTPUT INCREASED 30 0.1754
9 BLOOD LACTIC ACID DECREASED 30 0.1744
10 CEREBRAL VASODILATATION 1 0.1667
11 REEXPANSION PULMONARY OEDEMA 2 0.1667
12 BRONCHUS COMPRESSION 1 0.1429
13 ARTERECTOMY WITH GRAFT REPLACEMENT 1 0.1429
14 NEWBORN PERSISTENT PULMONARY HYPERTENSION 40 0.1423
15 HARLEQUIN SKIN REACTION 2 0.1333
16 PULMONARY HYPERTENSIVE CRISIS 36 0.1328
17 VITAMIN B1 DECREASED 33 0.1315
18 CATHETER SITE CALCIFICATION 1 0.1250
19 LUNG VOLUME REDUCTION SURGERY 2 0.1250
20 CONGENITAL PANCREATIC ANOMALY 1 0.1111
21 CARDIAC GRANULOMA 1 0.1000
22 CONGENITAL METHAEMOGLOBINAEMIA 1 0.1000
23 PULMONARY ARTERY WALL HYPERTROPHY 2 0.0952
24 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 46 0.0947
25 ANNULAR PANCREAS 1 0.0833
26 RIGHT VENTRICULAR SYSTOLIC PRESSURE 2 0.0800
27 PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY 6 0.0779
28 NEONATAL HYPOTENSION 27 0.0734
29 COAGULATION FACTOR VII LEVEL INCREASED 1 0.0667
30 EXTRACORPOREAL MEMBRANE OXYGENATION 3 0.0667
31 CARDIAC ARREST NEONATAL 9 0.0652
32 ATELECTASIS NEONATAL 7 0.0648
33 PATENT DUCTUS ARTERIOSUS REPAIR 3 0.0625
34 ANAEMIC HYPOXIA 1 0.0588
35 DRUG LEVEL FLUCTUATING 52 0.0586
36 PULMONARY VASCULAR RESISTANCE ABNORMALITY 5 0.0581
37 COR TRIATRIATUM 1 0.0556
38 PULMONARY CAPILLARY HAEMANGIOMATOSIS 3 0.0545
39 PULMONARY HAEMORRHAGE NEONATAL 5 0.0543
40 DEVICE TEMPERATURE ISSUE 4 0.0533
41 NEONATAL PULMONARY HYPERTENSION 2 0.0526
42 WITHDRAWAL OF LIFE SUPPORT 4 0.0494
43 VASCULAR GRAFT INFECTION 2 0.0455
44 HAEMODYNAMIC TEST ABNORMAL 3 0.0448
45 PULMONARY VEIN STENOSIS 5 0.0424
46 NEONATAL ANURIA 4 0.0421
47 BRONCHOPLASTY 1 0.0417
48 CORONARY ARTERY COMPRESSION 1 0.0400
49 PULMONARY ARTERIOPATHY 2 0.0400
50 NEONATAL RESPIRATORY ACIDOSIS 6 0.0395
51 RIGHT VENTRICULAR HYPERTENSION 2 0.0392
52 LOW CARDIAC OUTPUT SYNDROME 13 0.0389
53 BRONCHOPULMONARY DYSPLASIA 31 0.0385
54 HAEMORRHAGE NEONATAL 2 0.0385
55 CARDIO-RESPIRATORY ARREST NEONATAL 3 0.0385
56 DEVICE CALIBRATION FAILURE 2 0.0377
57 VASCULAR RESISTANCE SYSTEMIC DECREASED 5 0.0373
58 PULMONARY VEIN OCCLUSION 3 0.0370
59 NEONATAL PNEUMOTHORAX 2 0.0364
60 FAT EMBOLISM SYNDROME 2 0.0364
61 VASCULAR WALL HYPERTROPHY 2 0.0357
62 POSTPARTUM SEPSIS 2 0.0351
63 ACQUIRED MACROGLOSSIA 3 0.0337
64 NEONATAL CARDIAC FAILURE 3 0.0333
65 CENTRAL VENOUS PRESSURE INCREASED 4 0.0328
66 CONGENITAL SMALL INTESTINAL ATRESIA 1 0.0323
67 CARDIAC MONITORING ABNORMAL 1 0.0323
68 RETINOPATHY OF PREMATURITY 17 0.0307
69 CENTRAL VENOUS PRESSURE DECREASED 1 0.0286
70 VENOUS OXYGEN SATURATION DECREASED 2 0.0282
71 NEONATAL HYPOXIA 23 0.0278
72 DISSEMINATED TRICHOSPORONOSIS 2 0.0278
73 HARLEQUIN SYNDROME 2 0.0274
74 PULMONARY VENO-OCCLUSIVE DISEASE 19 0.0271
75 RIGHT-TO-LEFT CARDIAC SHUNT 6 0.0269
76 MENINGOCOCCAL SEPSIS 5 0.0263
77 NEONATAL RESPIRATORY FAILURE 13 0.0257
78 MULTIPLE CARDIAC DEFECTS 3 0.0248
79 GAS POISONING 2 0.0247
80 EXTUBATION 2 0.0247
81 NECROTISING ENTEROCOLITIS NEONATAL 10 0.0246
82 CATHETERISATION VENOUS 2 0.0244
83 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 2 0.0238
84 CEREBRAL HAEMORRHAGE NEONATAL 5 0.0236
85 DEATH NEONATAL 32 0.0230
86 BAROTRAUMA 2 0.0217
87 PULMONARY VASCULAR DISORDER 10 0.0212
88 PERIVENTRICULAR LEUKOMALACIA 6 0.0212
89 NEONATAL DYSPNOEA 2 0.0211
90 CARDIOMYOPATHY NEONATAL 1 0.0208
91 BALLOON ATRIAL SEPTOSTOMY 1 0.0208
92 BRADYCARDIA NEONATAL 26 0.0207
93 NEONATAL RESPIRATORY ARREST 3 0.0205
94 NECROTISING COLITIS 26 0.0205
95 NEONATAL DISORDER 32 0.0202
96 BASE EXCESS 1 0.0192
97 ENTEROBACTER PNEUMONIA 3 0.0192
98 PULMONARY OEDEMA NEONATAL 2 0.0192
99 FOETAL EXPOSURE DURING DELIVERY 13 0.0192
100 TUBEROUS SCLEROSIS COMPLEX 2 0.0190
101 INTESTINAL MALROTATION 5 0.0189
102 CONGENITAL SYPHILIS 1 0.0189
103 CANDIDA PNEUMONIA 6 0.0186
104 GAMMA-GLUTAMYLTRANSFERASE 2 0.0183
105 PERSISTENT FOETAL CIRCULATION 11 0.0180
106 BLOOD METHAEMOGLOBIN PRESENT 2 0.0180
107 EXPOSURE TO TOXIC AGENT 57 0.0178
108 INTERSTITIAL LUNG ABNORMALITY 2 0.0175
109 PATENT DUCTUS ARTERIOSUS 69 0.0174
110 PULMONARY ARTERIAL PRESSURE ABNORMAL 5 0.0174
111 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 6 0.0172
112 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 3 0.0172
113 PULMONARY ARTERIAL PRESSURE INCREASED 28 0.0172
114 CARBOXYHAEMOGLOBIN INCREASED 1 0.0167
115 CEREBRAL DYSGENESIS 1 0.0167
116 RIGHT VENTRICULAR DYSFUNCTION 18 0.0163
117 SHOCK SYMPTOM 6 0.0162
118 MEAN ARTERIAL PRESSURE DECREASED 4 0.0158
119 HAEMOFILTRATION 3 0.0158
120 RENAL REPLACEMENT THERAPY 2 0.0156
121 NEONATAL ASPHYXIA 11 0.0155
122 HEART AND LUNG TRANSPLANT 2 0.0155
123 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 16 0.0151
124 SEPSIS NEONATAL 12 0.0148
125 MYCETOMA MYCOTIC 2 0.0144
126 VENTILATION PERFUSION MISMATCH 4 0.0142
127 DRUG WITHDRAWAL MAINTENANCE THERAPY 2 0.0142
128 SHUNT MALFUNCTION 4 0.0141
129 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 2 0.0141
130 CARDIAC RESYNCHRONISATION THERAPY 1 0.0141
131 HYPOTHERMIA NEONATAL 2 0.0140
132 THORACOTOMY 2 0.0140
133 CSF SHUNT OPERATION 1 0.0139
134 NEONATAL RESPIRATORY DISTRESS 13 0.0138
135 BIOPSY LUNG 5 0.0136
136 RESPIRATORY TRACT HAEMORRHAGE 8 0.0134
137 ACID-BASE BALANCE DISORDER MIXED 1 0.0133
138 PERITONEAL HAEMATOMA 2 0.0133
139 NEURODEVELOPMENTAL DISORDER 9 0.0133
140 ATRIAL PRESSURE INCREASED 1 0.0132
141 BLOOD CREATININE 2 0.0131
142 CARDIAC CONTRACTILITY DECREASED 1 0.0130
143 CHORIOCARCINOMA 1 0.0127
144 ANAEMIA NEONATAL 6 0.0124
145 BACTERIAL TRACHEITIS 1 0.0123
146 ANOMALOUS PULMONARY VENOUS CONNECTION 3 0.0122
147 MATERNAL EXPOSURE DURING DELIVERY 12 0.0121
148 VENTRICULAR HYPOPLASIA 3 0.0120
149 COMPLEMENT FACTOR INCREASED 1 0.0119
150 CORD BLOOD TRANSPLANT THERAPY 1 0.0118
151 ATRIAL SEPTAL DEFECT REPAIR 2 0.0116
152 VENTRICULAR ENLARGEMENT 2 0.0114
153 TRACHEAL HAEMORRHAGE 4 0.0114
154 HYPERLACTACIDAEMIA 29 0.0108
155 CHEST EXPANSION DECREASED 1 0.0108
156 CEREBRAL HYPOPERFUSION 5 0.0107
157 PULMONARY HAEMORRHAGE 84 0.0107
158 CHEST TUBE INSERTION 2 0.0106
159 CONGENITAL PNEUMONIA 1 0.0105
160 HYPERTROPHIC CARDIOMYOPATHY 16 0.0103
161 BIOPSY LYMPH GLAND 1 0.0102
162 ASPLENIA 1 0.0101
163 RIGHT VENTRICULAR FAILURE 70 0.0100
164 BRONCHIAL FISTULA 2 0.0099
165 CARDIAC INDEX DECREASED 1 0.0097
166 DEVICE FAILURE 147 0.0096
167 METHAEMOGLOBINAEMIA 22 0.0095
168 DEVICE MALFUNCTION 660 0.0094
169 RIGHT VENTRICULAR ENLARGEMENT 3 0.0094
170 AMNIOTIC BAND SYNDROME 1 0.0091
171 CONGESTIVE HEPATOPATHY 4 0.0089
172 PULMONARY HYPOPLASIA 7 0.0089
173 NEONATAL RESPIRATORY DISTRESS SYNDROME 31 0.0088
174 PULMONARY ARTERY DILATATION 3 0.0087
175 INFANTILE APNOEIC ATTACK 2 0.0085
176 INTRAVENTRICULAR HAEMORRHAGE 21 0.0084
177 CARDIAC FAILURE HIGH OUTPUT 2 0.0083
178 ARRHYTHMIA NEONATAL 1 0.0081
179 ENTEROBACTER TEST POSITIVE 2 0.0081
180 PULMONARY RESECTION 2 0.0081
181 BRONCHOPLEURAL FISTULA 3 0.0080
182 ABDOMINAL COMPARTMENT SYNDROME 5 0.0078
183 APGAR SCORE LOW 10 0.0078
184 CONGENITAL DIAPHRAGMATIC HERNIA 3 0.0077
185 PULMONARY MUCORMYCOSIS 4 0.0076
186 ASPIRATION BONE MARROW 1 0.0075
187 THORACIC CAVITY DRAINAGE 2 0.0075
188 CONGENITAL BLADDER ANOMALY 1 0.0074
189 PULMONARY HYPERTENSION 154 0.0074
190 HYPOPLASTIC LEFT HEART SYNDROME 5 0.0074
191 ATRIAL ENLARGEMENT 2 0.0074
192 DEVICE ALARM ISSUE 13 0.0072
193 ALKALOSIS HYPOCHLORAEMIC 1 0.0071
194 HAEMATOMA EVACUATION 2 0.0071
195 CYSTIC LUNG DISEASE 1 0.0070
196 HYPOTONIA NEONATAL 11 0.0070
197 BURKHOLDERIA CEPACIA COMPLEX INFECTION 2 0.0070
198 CHYLOTHORAX 5 0.0069
199 MEDIASTINITIS 4 0.0069
200 COLLATERAL CIRCULATION 1 0.0069
201 ENDOTRACHEAL INTUBATION COMPLICATION 4 0.0068
202 LEFT-TO-RIGHT CARDIAC SHUNT 2 0.0068
203 RIGHT VENTRICULAR HYPERTROPHY 6 0.0066
204 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0066
205 UNDERDOSE 477 0.0065
206 CYANOSIS NEONATAL 4 0.0062
207 INFANTILE APNOEA 5 0.0061
208 CATARACT CONGENITAL 1 0.0059
209 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
210 PULMONARY NECROSIS 2 0.0059
211 ACUTE CHEST SYNDROME 5 0.0057
212 TRACHEOSTOMY 8 0.0056
213 PNEUMOMEDIASTINUM 10 0.0055
214 DEVICE ISSUE 475 0.0053
215 ANISOCORIA 2 0.0053
216 CHORIOAMNIONITIS 1 0.0053
217 LARYNGEAL STENOSIS 3 0.0052
218 BRONCHIAL IRRITATION 1 0.0052
219 PULMONARY ARTERY STENOSIS 2 0.0051
220 TRACHEOMALACIA 2 0.0051
221 LUNG DIFFUSION TEST DECREASED 2 0.0050
222 HAEMOPERITONEUM 4 0.0050
223 DEVICE RELATED SEPSIS 10 0.0050
224 OXYGEN SATURATION DECREASED 277 0.0049
225 CLUBBING 2 0.0049
226 DUCTUS ARTERIOSUS PREMATURE CLOSURE 2 0.0049
227 DIAPHRAGMATIC HERNIA 3 0.0048
228 CATHETER SEPSIS 1 0.0048
229 THROMBOCYTOPENIA NEONATAL 2 0.0048
230 CATHETER SITE INJURY 1 0.0047
231 HEARING AID USER 2 0.0047
232 HYPERCAPNIA 14 0.0046
233 SPINAL CORD INFARCTION 2 0.0045
234 PNEUMATOSIS 2 0.0045
235 CONGENITAL PULMONARY VALVE ATRESIA 1 0.0045
236 MITRAL VALVE STENOSIS 3 0.0045
237 DEVICE DELIVERY SYSTEM ISSUE 122 0.0045
238 CATHETER MANAGEMENT 4 0.0044
239 FEEDING INTOLERANCE 2 0.0044
240 LAPAROTOMY 2 0.0044
241 NO ADVERSE EVENT 789 0.0044
242 AORTIC THROMBOSIS 5 0.0043
243 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
244 COR PULMONALE 4 0.0042
245 CARDIAC VALVE REPLACEMENT COMPLICATION 1 0.0041
246 PULMONARY ALVEOLAR HAEMORRHAGE 23 0.0041
247 SUBCUTANEOUS EMPHYSEMA 4 0.0041
248 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
249 BRONCHIAL SECRETION RETENTION 5 0.0039
250 PNEUMOTHORAX 62 0.0039
251 ACUTE RESPIRATORY DISTRESS SYNDROME 69 0.0039
252 PLATELET TRANSFUSION 5 0.0039
253 CARDIAC VENTRICULAR THROMBOSIS 5 0.0039
254 AORTA HYPOPLASIA 1 0.0038
255 MYCOPLASMA INFECTION 3 0.0038
256 HYPOXIA 134 0.0038
257 SYSTOLIC DYSFUNCTION 4 0.0038
258 BLOOD LACTIC ACID INCREASED 20 0.0038
259 CONVULSION NEONATAL 2 0.0038
260 BRAIN MIDLINE SHIFT 2 0.0038
261 RESPIRATORY DISORDER NEONATAL 6 0.0037
262 CARDIOVASCULAR INSUFFICIENCY 6 0.0037
263 HAEMODYNAMIC INSTABILITY 28 0.0037
264 VASOPLEGIA SYNDROME 6 0.0037
265 DEAFNESS NEUROSENSORY 12 0.0036
266 BULBAR PALSY 1 0.0036
267 CHEMICAL BURNS OF EYE 1 0.0036
268 COR PULMONALE ACUTE 1 0.0036
269 ENCEPHALOMALACIA 2 0.0036
270 AGONAL RESPIRATION 1 0.0035
271 PO2 DECREASED 4 0.0035
272 RIGHT VENTRICULAR DILATATION 2 0.0035
273 VASOCONSTRICTION 3 0.0034
274 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
275 BONE METABOLISM DISORDER 1 0.0033
276 PULMONARY ARTERIAL HYPERTENSION 48 0.0033
277 INFECTIOUS PLEURAL EFFUSION 5 0.0033
278 HYDROPS FOETALIS 2 0.0033
279 PANCREATIC NEOPLASM 4 0.0032
280 CATHETER SITE SWELLING 3 0.0032
281 HEART VALVE INCOMPETENCE 9 0.0031
282 NECROTISING RETINITIS 2 0.0031
283 PNEUMONIA NECROTISING 2 0.0031
284 DEVICE POWER SOURCE ISSUE 9 0.0031
285 KLEBSIELLA TEST POSITIVE 2 0.0031
286 ILEAL PERFORATION 2 0.0030
287 ACIDOSIS 23 0.0030
288 ARRHYTHMIC STORM 1 0.0030
289 SUBSTANCE DEPENDENCE 2 0.0030
290 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0029
291 VIRAEMIA 4 0.0029
292 ANION GAP DECREASED 1 0.0029
293 FUSARIUM INFECTION 2 0.0029
294 HYPOPERFUSION 3 0.0029
295 ANOXIA 1 0.0028
296 CHRONIC RESPIRATORY DISEASE 1 0.0028
297 SUTURE RELATED COMPLICATION 2 0.0028
298 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
299 OCCUPATIONAL EXPOSURE TO PRODUCT 18 0.0028
300 COMPLICATIONS OF TRANSPLANTED LIVER 1 0.0028
301 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
302 INFANTILE SPASMS 2 0.0028
303 HAEMOTHORAX 8 0.0028
304 CEREBRAL MASS EFFECT 1 0.0028
305 SYSTEMIC SCLERODERMA 2 0.0027
306 PULMONARY CONGESTION 36 0.0027
307 VENTRICULAR DYSFUNCTION 7 0.0027
308 MULTIPLE ORGAN DYSFUNCTION SYNDROME 75 0.0026
309 HEPARIN-INDUCED THROMBOCYTOPENIA 13 0.0026
310 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
311 CEREBRAL VENTRICLE DILATATION 3 0.0026
312 DEBRIDEMENT 2 0.0026
313 CAPILLARY DISORDER 1 0.0026
314 TRAUMATIC LUNG INJURY 5 0.0026
315 AORTIC RUPTURE 1 0.0026
316 SINUS ARREST 4 0.0025
317 PULMONARY INFARCTION 6 0.0025
318 OXYGEN CONSUMPTION INCREASED 6 0.0025
319 PNEUMONIA LEGIONELLA 4 0.0025
320 STRONGYLOIDIASIS 4 0.0025
321 BIOPSY LIVER 1 0.0024
322 CARDIAC VENTRICULAR DISORDER 1 0.0024
323 DEVICE OCCLUSION 34 0.0024
324 LIVEDO RETICULARIS 5 0.0024
325 LOW BIRTH WEIGHT BABY 19 0.0024
326 ATELECTASIS 23 0.0024
327 ABDOMINAL CAVITY DRAINAGE 1 0.0024
328 DEVICE CONNECTION ISSUE 5 0.0024
329 CARDIOGENIC SHOCK 34 0.0024
330 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
331 CAROTID ARTERY DISSECTION 1 0.0023
332 CORONA VIRUS INFECTION 1 0.0023
333 PREMATURE BABY 70 0.0023
334 PREMATURE DELIVERY 37 0.0023
335 RHINOVIRUS INFECTION 9 0.0023
336 ABDOMINAL SEPSIS 2 0.0023
337 DEVICE MISUSE 3 0.0023
338 LUNG TRANSPLANT 8 0.0023
339 ANAEMIA MEGALOBLASTIC 1 0.0022
340 BRADYPNOEA 6 0.0022
341 CEREBRAL MICROHAEMORRHAGE 1 0.0022
342 RESPIRATORY FAILURE 159 0.0022
343 BEZOAR 3 0.0022
344 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
345 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0021
346 HEPATIC CONGESTION 2 0.0021
347 OLIGURIA 13 0.0021
348 BLASTOMYCOSIS 1 0.0021
349 BRAIN DAMAGE 1 0.0020
350 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
351 PRODUCT USE ISSUE 377 0.0020
352 VENOOCCLUSIVE DISEASE 5 0.0020
353 DRUG TITRATION ERROR 5 0.0019
354 SUBSTANCE USE 3 0.0019
355 FEEDING DISORDER NEONATAL 2 0.0019
356 ATRIAL TACHYCARDIA 4 0.0019
357 NON-CARDIOGENIC PULMONARY OEDEMA 2 0.0019
358 CARDIAC DYSFUNCTION 7 0.0019
359 GALLBLADDER ENLARGEMENT 2 0.0019
360 BLOOD GASES ABNORMAL 1 0.0019
361 LIVER ABSCESS 6 0.0018
362 CRYSTALLURIA 1 0.0018
363 KIDNEY ENLARGEMENT 2 0.0018
364 BRONCHOSTENOSIS 1 0.0018
365 ACINETOBACTER INFECTION 2 0.0018
366 HYPERVOLAEMIA 9 0.0018
367 BLOOD PH INCREASED 1 0.0018
368 EPSTEIN-BARR VIRAEMIA 2 0.0018
369 CARDIAC HYPERTROPHY 2 0.0018
370 BRAIN SCAN ABNORMAL 1 0.0018
371 APNOEIC ATTACK 1 0.0018
372 CYTOGENETIC ABNORMALITY 2 0.0018
373 SPLEEN DISORDER 3 0.0018
374 BLOOD PH DECREASED 3 0.0018
375 BLOODY DISCHARGE 2 0.0017
376 CARDIO-RESPIRATORY ARREST 73 0.0017
377 THERAPY NON-RESPONDER 78 0.0017
378 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
379 DILATATION ATRIAL 2 0.0017
380 ESCHERICHIA BACTERAEMIA 4 0.0017
381 INTESTINAL PERFORATION 19 0.0017
382 AORTIC DISSECTION 7 0.0017
383 NEPHROCALCINOSIS 2 0.0017
384 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
385 ASPERGILLUS INFECTION 11 0.0017
386 DYSPLASIA 2 0.0017
387 CARDIAC DEATH 2 0.0017
388 PNEUMONIA KLEBSIELLA 3 0.0016
389 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
390 BRAIN DEATH 5 0.0016
391 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
392 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
393 PULMONARY OEDEMA 72 0.0016
394 BACILLUS INFECTION 1 0.0016
395 CATHETERISATION CARDIAC 7 0.0016
396 TONIC CLONIC MOVEMENTS 2 0.0015
397 CONCOMITANT DISEASE PROGRESSION 3 0.0015
398 BACTERIAL SEPSIS 5 0.0015
399 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 84 0.0015
400 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
401 ACQUIRED GENE MUTATION 2 0.0015
402 OESOPHAGEAL HAEMORRHAGE 2 0.0015
403 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
404 BRONCHITIS VIRAL 1 0.0015
405 CARDIAC ARREST 122 0.0015
406 STENOTROPHOMONAS INFECTION 2 0.0015
407 PERIPHERAL ISCHAEMIA 6 0.0015
408 CYTOKINE STORM 1 0.0015
409 CEREBRAL CYST 1 0.0015
410 POLYCYTHAEMIA 3 0.0015
411 COAGULOPATHY 24 0.0014
412 ENDOTRACHEAL INTUBATION 4 0.0014
413 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
414 PRERENAL FAILURE 2 0.0014
415 STAPHYLOCOCCAL SEPSIS 7 0.0014
416 INTENSIVE CARE 2 0.0014
417 CATHETER SITE ERYTHEMA 3 0.0014
418 CEREBELLAR HAEMORRHAGE 2 0.0014
419 AMNIOTIC CAVITY INFECTION 1 0.0014
420 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
421 CLONIC CONVULSION 1 0.0014
422 BRAIN STEM SYNDROME 1 0.0013
423 CHEST X-RAY ABNORMAL 4 0.0013
424 PNEUMONIA PSEUDOMONAL 2 0.0013
425 ASPIRATION PLEURAL CAVITY 1 0.0013
426 COAGULATION TEST ABNORMAL 1 0.0013
427 PREMATURE SEPARATION OF PLACENTA 2 0.0013
428 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
429 HYDROCEPHALUS 7 0.0013
430 CARDIOPULMONARY FAILURE 5 0.0013
431 PROCEDURAL HAEMORRHAGE 5 0.0013
432 PULMONARY TOXICITY 9 0.0013
433 RESPIRATORY ACIDOSIS 5 0.0013
434 INTESTINAL OPERATION 2 0.0013
435 TRICUSPID VALVE INCOMPETENCE 10 0.0013
436 HYPOVOLAEMIC SHOCK 6 0.0013
437 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0012
438 RESPIRATORY ALKALOSIS 2 0.0012
439 HEPATIC NEOPLASM 4 0.0012
440 SHOCK 28 0.0012
441 COLLAPSE OF LUNG 1 0.0012
442 STEM CELL TRANSPLANT 3 0.0012
443 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
444 CATHETER SITE HAEMORRHAGE 3 0.0012
445 CULTURE POSITIVE 1 0.0012
446 VENTRICULAR HYPERTROPHY 3 0.0012
447 LIVE BIRTH 10 0.0012
448 VASODILATATION 3 0.0012
449 ENTEROBACTER INFECTION 2 0.0012
450 KLEBSIELLA INFECTION 6 0.0012
451 HAEMORRHAGE URINARY TRACT 3 0.0012
452 LACTIC ACIDOSIS 38 0.0012
453 VENTRICULAR FIBRILLATION 13 0.0012
454 LEFT VENTRICULAR FAILURE 4 0.0012
455 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
456 CATHETER SITE PAIN 3 0.0012
457 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
458 ABDOMINAL LYMPHADENOPATHY 1 0.0012
459 REBOUND EFFECT 13 0.0011
460 EXTREMITY NECROSIS 2 0.0011
461 TRANSFUSION 12 0.0011
462 CLEFT LIP 1 0.0011
463 CEREBELLAR ATROPHY 1 0.0011
464 HYPOPHAGIA 29 0.0011
465 HISTOPLASMOSIS 2 0.0011
466 CAESAREAN SECTION 13 0.0011
467 CANDIDA SEPSIS 1 0.0011
468 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
469 LIVER TRANSPLANT 4 0.0011
470 VENOUS OCCLUSION 2 0.0011
471 BACTERAEMIA 13 0.0011
472 MEDICAL DEVICE COMPLICATION 8 0.0011
473 CATHETER PLACEMENT 2 0.0011
474 ADENOCARCINOMA GASTRIC 1 0.0011
475 LUNG CONSOLIDATION 3 0.0011
476 RETINOPATHY 4 0.0011
477 BRAIN STEM HAEMORRHAGE 1 0.0011
478 JAUNDICE NEONATAL 2 0.0011
479 CIRCULATORY COLLAPSE 18 0.0011
480 PRE-ECLAMPSIA 5 0.0011
481 PNEUMATOSIS INTESTINALIS 3 0.0011
482 HYPERCOAGULATION 2 0.0010
483 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
484 COARCTATION OF THE AORTA 1 0.0010
485 SEPTIC SHOCK 45 0.0010
486 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
487 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
488 DIPLEGIA 2 0.0010
489 ORGANISING PNEUMONIA 5 0.0010
490 BRAIN HYPOXIA 1 0.0010
491 BUTTERFLY RASH 1 0.0010
492 NO THERAPEUTIC RESPONSE 12 0.0010
493 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
494 DIASTOLIC DYSFUNCTION 3 0.0010
495 GENERALISED OEDEMA 12 0.0010
496 ATRIAL THROMBOSIS 2 0.0010
497 CAPILLARY LEAK SYNDROME 2 0.0010
498 MULTIPLE-DRUG RESISTANCE 3 0.0010
499 BONE MARROW OEDEMA 1 0.0010
500 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
501 HEART RATE DECREASED 33 0.0009
502 POOR PERIPHERAL CIRCULATION 4 0.0009
503 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 1 0.0009
504 HYPOVENTILATION 3 0.0009
505 THROMBOSIS IN DEVICE 3 0.0009
506 PERICARDIAL HAEMORRHAGE 2 0.0009
507 CARDIAC AMYLOIDOSIS 1 0.0009
508 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
509 INTESTINAL ISCHAEMIA 5 0.0009
510 HAEMOLYSIS 7 0.0009
511 BLOOD UREA INCREASED 15 0.0009
512 PSEUDOMEMBRANOUS COLITIS 2 0.0009
513 CEREBRAL HAEMATOMA 3 0.0009
514 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
515 BRADYCARDIA 47 0.0009
516 CORTISOL DECREASED 1 0.0009
517 DISEASE COMPLICATION 4 0.0009
518 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
519 POST PROCEDURAL HAEMORRHAGE 10 0.0009
520 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
521 BILIRUBIN CONJUGATED INCREASED 2 0.0009
522 PRODUCT USE IN UNAPPROVED INDICATION 211 0.0009
523 LONG QT SYNDROME 2 0.0008
524 CHRONIC RESPIRATORY FAILURE 1 0.0008
525 PARADOXICAL DRUG REACTION 3 0.0008
526 RETROPERITONEAL HAEMORRHAGE 2 0.0008
527 TACHYPNOEA 11 0.0008
528 LEUKOENCEPHALOPATHY 3 0.0008
529 HYPERNATRAEMIA 4 0.0008
530 RESPIRATORY DISTRESS 22 0.0008
531 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
532 PROCEDURAL COMPLICATION 6 0.0008
533 INCREASED BRONCHIAL SECRETION 2 0.0008
534 BLOOD BILIRUBIN ABNORMAL 1 0.0008
535 ENDOCARDITIS 4 0.0008
536 CEREBRAL ISCHAEMIA 4 0.0008
537 APNOEA 6 0.0008
538 FOETAL EXPOSURE DURING PREGNANCY 62 0.0008
539 PNEUMONIA BACTERIAL 7 0.0008
540 LUNG OPACITY 2 0.0008
541 CORONAVIRUS INFECTION 5 0.0008
542 CEREBRAL HAEMORRHAGE 27 0.0008
543 MULTI-ORGAN FAILURE 13 0.0008
544 BLOOD PRESSURE DECREASED 49 0.0007
545 SHOCK HAEMORRHAGIC 6 0.0007
546 NORMAL NEWBORN 4 0.0007
547 SUBDURAL HAEMORRHAGE 2 0.0007
548 VENTRICULAR TACHYCARDIA 12 0.0007
549 GASTROINTESTINAL PERFORATION 3 0.0007
550 CARDIOVERSION 1 0.0007
551 BRONCHIAL OBSTRUCTION 1 0.0007
552 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
553 OXYGEN SATURATION ABNORMAL 2 0.0007
554 HYPOTENSION 141 0.0007
555 PULMONARY TUBERCULOSIS 3 0.0007
556 PSEUDOMONAS INFECTION 6 0.0007
557 CYANOSIS 11 0.0007
558 SPEECH DISORDER DEVELOPMENTAL 2 0.0007
559 FLUID OVERLOAD 10 0.0007
560 LUNG INFILTRATION 6 0.0007
561 COVID-19 PNEUMONIA 8 0.0007
562 VENTRICULAR EXTRASYSTOLES 7 0.0007
563 ANGIOPLASTY 1 0.0007
564 BRAIN HERNIATION 2 0.0007
565 CONDITION AGGRAVATED 201 0.0007
566 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
567 DEVICE PHYSICAL PROPERTY ISSUE 5 0.0007
568 INTRACARDIAC THROMBUS 2 0.0007
569 MATERNAL EXPOSURE DURING PREGNANCY 58 0.0007
570 ASPIRATION 7 0.0006
571 SUBSTANCE USE DISORDER 2 0.0006
572 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
573 PALLOR 17 0.0006
574 AORTIC VALVE DISEASE 1 0.0006
575 ACUTE LEUKAEMIA 1 0.0006
576 THROMBOTIC MICROANGIOPATHY 6 0.0006
577 HEPATOMEGALY 6 0.0006
578 SMALL FOR DATES BABY 3 0.0006
579 EXPOSURE DURING PREGNANCY 37 0.0006
580 EMPHYSEMA 6 0.0006
581 METABOLIC ACIDOSIS 19 0.0006
582 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
583 WOUND DEHISCENCE 2 0.0006
584 BRONCHOPNEUMONIA 2 0.0006
585 CARDIAC MURMUR 5 0.0006
586 FAILURE TO THRIVE 3 0.0006
587 INTENTIONAL OVERDOSE 37 0.0006
588 HYPOPNOEA 2 0.0006
589 HYPERTRANSAMINASAEMIA 4 0.0006
590 ACUTE RESPIRATORY FAILURE 11 0.0006
591 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
592 SEPSIS 62 0.0006
593 HAEMOPTYSIS 15 0.0005
594 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
595 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
596 ABORTION INDUCED 5 0.0005
597 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
598 PULMONARY FIBROSIS 10 0.0005
599 DEVICE RELATED INFECTION 8 0.0005
600 CLEFT PALATE 1 0.0005
601 CEREBRAL ATROPHY 2 0.0005
602 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
603 ORGAN FAILURE 2 0.0005
604 DRUG LEVEL INCREASED 8 0.0005
605 HYPERBILIRUBINAEMIA 5 0.0005
606 ACCIDENTAL EXPOSURE 2 0.0005
607 HAEMODIALYSIS 4 0.0005
608 CARDIAC FAILURE 38 0.0005
609 TACHYCARDIA 42 0.0005
610 HYPERPYREXIA 2 0.0005
611 POST PROCEDURAL COMPLICATION 9 0.0005
612 ANURIA 4 0.0005
613 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
614 CLOSTRIDIUM TEST POSITIVE 1 0.0005
615 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
616 RESPIRATORY RATE INCREASED 4 0.0005
617 CARDIAC FAILURE ACUTE 3 0.0004
618 DEATH 387 0.0004
619 HAEMOLYTIC ANAEMIA 4 0.0004
620 VASCULAR DEVICE INFECTION 2 0.0004
621 PATHOGEN RESISTANCE 4 0.0004
622 MYOCARDITIS 5 0.0004
623 ISCHAEMIA 2 0.0004
624 CHRONIC MYELOID LEUKAEMIA 2 0.0004
625 SINUS TACHYCARDIA 6 0.0004
626 ENTEROCOCCAL INFECTION 2 0.0004
627 INFLAMMATORY MARKER INCREASED 2 0.0004
628 ANEURYSM 2 0.0004
629 HAEMORRHAGE INTRACRANIAL 6 0.0004
630 RESPIRATORY DISORDER 12 0.0004
631 BRAIN OEDEMA 5 0.0004
632 MOTOR DYSFUNCTION 4 0.0004
633 INTERSTITIAL LUNG DISEASE 19 0.0004
634 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
635 OFF LABEL USE 342 0.0004
636 MYDRIASIS 5 0.0004
637 INFUSION SITE PAIN 5 0.0004
638 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
639 COMPARTMENT SYNDROME 1 0.0004
640 TORSADE DE POINTES 3 0.0004
641 COVID-19 67 0.0004
642 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
643 TRANSPLANT REJECTION 3 0.0004
644 ANAESTHETIC COMPLICATION 1 0.0004
645 CEREBRAL INFARCTION 9 0.0004
646 ACUTE KIDNEY INJURY 56 0.0004
647 HEMIPLEGIA 3 0.0004
648 INTRACRANIAL PRESSURE INCREASED 2 0.0004
649 ATRIAL SEPTAL DEFECT 3 0.0004
650 ANGIOPATHY 2 0.0004
651 INFUSION SITE ERYTHEMA 3 0.0004
652 PREMATURE LABOUR 2 0.0004
653 CEREBRAL THROMBOSIS 1 0.0004
654 CHOLECYSTITIS ACUTE 2 0.0004
655 PERONEAL NERVE PALSY 2 0.0004
656 VENTRICULAR SEPTAL DEFECT 2 0.0003
657 PLEURAL EFFUSION 21 0.0003
658 METABOLIC DISORDER 2 0.0003
659 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
660 URINE OUTPUT DECREASED 3 0.0003
661 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
662 HYPOVOLAEMIA 2 0.0003
663 ASCITES 10 0.0003
664 WRONG DRUG ADMINISTERED 3 0.0003
665 CREPITATIONS 1 0.0003
666 HEART RATE INCREASED 33 0.0003
667 DEVELOPMENTAL DELAY 3 0.0003
668 GANGRENE 2 0.0003
669 CENTRAL VENOUS CATHETERISATION 1 0.0003
670 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
671 RESPIRATORY ARREST 9 0.0003
672 LARYNGEAL OEDEMA 2 0.0003
673 PRODUCT PRESCRIBING ISSUE 7 0.0003
674 PULMONARY EMBOLISM 30 0.0003
675 CHOLESTASIS 6 0.0003
676 GENITAL HAEMORRHAGE 4 0.0003
677 RESPIRATORY TRACT INFECTION 8 0.0003
678 THROMBOCYTOPENIA 34 0.0003
679 STAPHYLOCOCCAL INFECTION 10 0.0003
680 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
681 HYPERGLYCAEMIA 11 0.0003
682 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
683 BRAIN INJURY 3 0.0003
684 HEPATIC FAILURE 9 0.0003
685 SUBARACHNOID HAEMORRHAGE 3 0.0003
686 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
687 RESPIRATION ABNORMAL 2 0.0003
688 LARGE INTESTINE PERFORATION 2 0.0003
689 FORMICATION 2 0.0003
690 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
691 PNEUMONIA ASPIRATION 7 0.0003
692 PARAESTHESIA ORAL 4 0.0003
693 OSTEOMYELITIS 5 0.0003
694 C-REACTIVE PROTEIN INCREASED 10 0.0003
695 UNRESPONSIVE TO STIMULI 7 0.0003
696 CEREBRAL DISORDER 2 0.0003
697 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
698 HEPATOTOXICITY 6 0.0003
699 AGRANULOCYTOSIS 5 0.0003
700 CHRONIC SINUSITIS 1 0.0003
701 MITRAL VALVE INCOMPETENCE 3 0.0003
702 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
703 PLATELET COUNT DECREASED 28 0.0003
704 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
705 RENAL FAILURE ACUTE 11 0.0003
706 HYPOALBUMINAEMIA 2 0.0003
707 HAEMORRHAGIC STROKE 2 0.0003
708 RENAL FAILURE 34 0.0003
709 DRUG INEFFECTIVE 332 0.0003
710 TOXICITY TO VARIOUS AGENTS 42 0.0002
711 SENSORY LOSS 2 0.0002
712 SMALL INTESTINAL OBSTRUCTION 3 0.0002
713 HEPATIC FUNCTION ABNORMAL 9 0.0002
714 DRUG USE DISORDER 2 0.0002
715 AORTIC VALVE INCOMPETENCE 1 0.0002
716 FACIAL PARALYSIS 2 0.0002
717 CARDIAC OPERATION 2 0.0002
718 THERAPEUTIC RESPONSE DECREASED 14 0.0002
719 ORAL CANDIDIASIS 3 0.0002
720 TUMOUR LYSIS SYNDROME 2 0.0002
721 SARS-COV-2 TEST POSITIVE 3 0.0002
722 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
723 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
724 LUNG DISORDER 11 0.0002
725 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
726 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
727 ABDOMINAL HERNIA 1 0.0002
728 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
729 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
730 MEDICATION ERROR 12 0.0002
731 DYSPNOEA EXERTIONAL 8 0.0002
732 HAEMORRHAGE 22 0.0002
733 CARDIAC TAMPONADE 1 0.0002
734 FUNGAL INFECTION 7 0.0002
735 SUBDURAL HAEMATOMA 3 0.0002
736 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
737 DEVICE LEAKAGE 9 0.0002
738 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
739 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
740 ACUTE MYOCARDIAL INFARCTION 6 0.0002
741 CARDIOMYOPATHY 3 0.0002
742 DISEASE PROGRESSION 24 0.0002
743 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
744 RENAL IMPAIRMENT 17 0.0002
745 CORONARY ARTERY STENOSIS 1 0.0002
746 BLOOD COUNT ABNORMAL 3 0.0002
747 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
748 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
749 THERAPY PARTIAL RESPONDER 3 0.0002
750 LETHARGY 11 0.0002
751 ANAL FISSURE 1 0.0002
752 DECREASED ACTIVITY 2 0.0002
753 CYSTIC FIBROSIS 1 0.0002
754 CYTOMEGALOVIRUS INFECTION 3 0.0002
755 LEUKOPENIA 9 0.0002
756 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
757 ACUTE PULMONARY OEDEMA 1 0.0002
758 CANDIDA INFECTION 3 0.0002
759 HEMIPARESIS 3 0.0002
760 STATUS EPILEPTICUS 2 0.0002
761 COLECTOMY 1 0.0002
762 CARDIAC VALVE DISEASE 1 0.0002
763 PERICARDIAL EFFUSION 4 0.0002
764 HYPERKALAEMIA 6 0.0002
765 ISCHAEMIC STROKE 3 0.0002
766 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
767 OEDEMA 9 0.0002
768 LEUKOCYTOSIS 3 0.0002
769 BONE DISORDER 3 0.0002
770 ATRIAL FIBRILLATION 16 0.0002
771 EPILEPSY 5 0.0002
772 LIVER INJURY 4 0.0002
773 CARDIOMEGALY 2 0.0002
774 CYST 2 0.0002
775 ILEUS 2 0.0002
776 SYNCOPE 16 0.0002
777 PNEUMONIA 51 0.0002
778 FLUID RETENTION 8 0.0002
779 HEPATITIS 4 0.0002
780 PRESCRIBED OVERDOSE 3 0.0002
781 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
782 BLOOD PRESSURE ABNORMAL 3 0.0002
783 COGNITIVE DISORDER 7 0.0001
784 PREGNANCY 3 0.0001
785 BRONCHIECTASIS 1 0.0001
786 BONE MARROW FAILURE 3 0.0001
787 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
788 ACUTE HEPATIC FAILURE 2 0.0001
789 PERITONITIS 3 0.0001
790 ABDOMINAL DISTENSION 15 0.0001
791 HYPONATRAEMIA 8 0.0001
792 DIALYSIS 2 0.0001
793 BRONCHOSPASM 2 0.0001
794 INFECTION 20 0.0001
795 GASTROENTERITIS 2 0.0001
796 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
797 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
798 RENAL INJURY 4 0.0001
799 HYPOAESTHESIA ORAL 2 0.0001
800 AORTIC ANEURYSM 1 0.0001
801 HYPOKALAEMIA 6 0.0001
802 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
803 CARDIAC DISORDER 12 0.0001
804 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
805 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
806 ARRHYTHMIA 6 0.0001
807 DISEASE RECURRENCE 6 0.0001
808 ANAEMIA 24 0.0001
809 BLOOD DISORDER 1 0.0001
810 BLOOD POTASSIUM INCREASED 2 0.0001
811 ASPHYXIA 1 0.0001
812 ACUTE CORONARY SYNDROME 1 0.0001
813 EPISTAXIS 9 0.0001
814 CARDIOVASCULAR DISORDER 3 0.0001
815 BLOOD MAGNESIUM DECREASED 1 0.0001
816 HAEMATOMA 3 0.0001
817 DELIRIUM 4 0.0001
818 GALLBLADDER DISORDER 2 0.0001
819 THROMBOSIS 9 0.0001
820 PNEUMONITIS 3 0.0001
821 TREATMENT NONCOMPLIANCE 6 0.0001
822 SKIN DISCOLOURATION 5 0.0001
823 MENTAL STATUS CHANGES 3 0.0001
824 COMPLETED SUICIDE 9 0.0001
825 HEPATIC STEATOSIS 2 0.0001
826 BLOOD CREATININE INCREASED 7 0.0001
827 BACTERIAL INFECTION 2 0.0001
828 OVERDOSE 23 0.0001
829 HOT FLUSH 8 0.0001
830 COLITIS 4 0.0001
831 DYSPHAGIA 10 0.0001
832 SLEEP APNOEA SYNDROME 2 0.0001
833 SEIZURE 12 0.0001
834 HAEMATOCRIT DECREASED 2 0.0001
835 CYTOKINE RELEASE SYNDROME 2 0.0001
836 FULL BLOOD COUNT DECREASED 2 0.0001
837 FEEDING DISORDER 2 0.0001
838 DEVICE BREAKAGE 4 0.0001
839 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
840 TREATMENT FAILURE 8 0.0001
841 NERVOUS SYSTEM DISORDER 3 0.0001
842 AGITATION 7 0.0001
843 HALLUCINATION, VISUAL 2 0.0001
844 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
845 TRANSAMINASES INCREASED 2 0.0001
846 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
847 BLOOD CALCIUM DECREASED 1 0.0001
848 FLUSHING 9 0.0001
849 HAEMATURIA 3 0.0001
850 SURGERY 5 0.0001
851 NASAL CONGESTION 5 0.0001
852 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
853 BLOOD IRON DECREASED 1 0.0001
854 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
855 MENTAL IMPAIRMENT 2 0.0001
856 PYREXIA 28 0.0001
857 INTESTINAL OBSTRUCTION 3 0.0001
858 HAEMOGLOBIN DECREASED 8 0.0001
859 SEDATION 2 0.0001
860 FEBRILE NEUTROPENIA 5 0.0001
861 FEAR 2 0.0001
862 JAUNDICE 2 0.0001
863 BLOOD BILIRUBIN INCREASED 2 0.0001
864 PROCEDURAL PAIN 2 0.0001
865 FEELING COLD 2 0.0001
866 ROAD TRAFFIC ACCIDENT 3 0.0001
867 PANCYTOPENIA 4 0.0001
868 CEREBROVASCULAR ACCIDENT 12 0.0001
869 ACCIDENTAL UNDERDOSE 1 0.0001
870 LIVER FUNCTION TEST ABNORMAL 2 0.0001
871 COLON CANCER 1 0.0001
872 IRRITABILITY 4 0.0001
873 UNEVALUABLE EVENT 5 0.0001
874 DRUG ADMINISTRATION ERROR 2 0.0001
875 LIMB DISCOMFORT 2 0.0001
876 ACUTE MYELOID LEUKAEMIA 1 0.0001
877 SWELLING 6 0.0001
878 BRAIN FOG 1 0.0001
879 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
880 COMA 3 0.0001
881 DYSPNOEA 35 0.0001
882 DRY MOUTH 5 0.0001
883 DEEP VEIN THROMBOSIS 4 0.0001
884 OSTEONECROSIS 2 0.0001
885 VIRAL INFECTION 2 0.0001
886 NEUTROPENIA 8 0.0001
887 THERAPY CESSATION 3 0.0001
888 PERIPHERAL SWELLING 9 0.0001
889 INFLAMMATION 3 0.0001
890 DEVICE USE ERROR 2 0.0001
891 INJURY 4 0.0001
892 DRUG EFFECT INCOMPLETE 2 0.0001
893 ACCIDENTAL OVERDOSE 2 0.0001
894 RESTLESSNESS 2 0.0001
895 ANAPHYLACTIC REACTION 3 0.0001
896 CONJUNCTIVITIS 1 0.0001
897 CONVULSION 3 0.0001
898 WHEEZING 3 0.0001
899 COMPLICATION OF DEVICE INSERTION 1 0.0001
900 CARDIAC FAILURE CONGESTIVE 4 0.0000
901 JOINT SWELLING 6 0.0000
902 BODY TEMPERATURE INCREASED 1 0.0000
903 ILLNESS 5 0.0000
904 RHABDOMYOLYSIS 2 0.0000
905 SWELLING FACE 3 0.0000
906 DEVICE DISLOCATION 2 0.0000
907 LIVER DISORDER 2 0.0000
908 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
909 DRUG INTERACTION 7 0.0000
910 TINNITUS 2 0.0000
911 RENAL DISORDER 2 0.0000
912 BRONCHITIS 3 0.0000
913 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
914 ABDOMINAL PAIN LOWER 1 0.0000
915 CHRONIC KIDNEY DISEASE 3 0.0000
916 WEIGHT DECREASED 11 0.0000
917 BLOOD PRESSURE INCREASED 6 0.0000
918 CHEST DISCOMFORT 4 0.0000
919 LOSS OF CONSCIOUSNESS 5 0.0000
920 ANAPHYLACTIC SHOCK 1 0.0000
921 VOMITING 18 0.0000
922 SPEECH DISORDER 2 0.0000
923 ANHEDONIA 1 0.0000
924 DERMATITIS ATOPIC 2 0.0000
925 PANCREATITIS 2 0.0000
926 DEHYDRATION 5 0.0000
927 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
928 DRUG EFFECT DECREASED 2 0.0000
929 HAEMATOCHEZIA 2 0.0000
930 DRUG ABUSE 3 0.0000
931 HEADACHE 22 0.0000
932 ANGINA PECTORIS 1 0.0000
933 PRODUCT SUBSTITUTION ISSUE 2 0.0000
934 INTENTIONAL PRODUCT MISUSE 3 0.0000
935 GASTROINTESTINAL DISORDER 3 0.0000
936 BLOOD POTASSIUM DECREASED 1 0.0000
937 HYPERTENSION 7 0.0000
938 CORONARY ARTERY DISEASE 1 0.0000
939 OEDEMA PERIPHERAL 4 0.0000
940 COUGH 9 0.0000
941 NEUROPATHY PERIPHERAL 3 0.0000
942 CRYING 1 0.0000
943 DYSGEUSIA 2 0.0000
944 HOSPITALISATION 4 0.0000
945 ARTHRITIS 2 0.0000
946 DIARRHOEA 16 0.0000
947 ERYTHEMA 5 0.0000
948 NAUSEA 19 0.0000
949 URTICARIA 4 0.0000
950 MYOCARDIAL INFARCTION 4 0.0000
951 CHEST PAIN 4 0.0000
952 DRUG INTOLERANCE 2 0.0000
953 MALAISE 9 0.0000
954 ALOPECIA 4 0.0000
955 AGGRESSION 1 0.0000
956 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
957 SINUSITIS 2 0.0000
958 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
959 PARAESTHESIA 3 0.0000
960 DRUG DEPENDENCE 3 0.0000
961 DIZZINESS 9 0.0000
962 ARTHROPATHY 1 0.0000
963 INFLUENZA 2 0.0000
964 WEIGHT INCREASED 4 0.0000
965 MUSCULAR WEAKNESS 2 0.0000
966 URINARY TRACT INFECTION 3 0.0000
967 ANXIETY 5 0.0000
968 INCORRECT DOSE ADMINISTERED 4 0.0000
969 PALPITATIONS 2 0.0000
970 FEELING ABNORMAL 4 0.0000
971 EMOTIONAL DISTRESS 2 0.0000
972 ASTHENIA 6 0.0000
973 BLOOD GLUCOSE INCREASED 3 0.0000
974 AMNESIA 1 0.0000
975 DRY SKIN 2 0.0000
976 DECREASED APPETITE 3 0.0000
977 FATIGUE 10 0.0000
978 TREMOR 2 0.0000
979 ABDOMINAL DISCOMFORT 2 0.0000
980 PAIN 7 0.0000
981 ADVERSE DRUG REACTION 1 0.0000
982 MUSCLE SPASMS 2 0.0000
983 ADVERSE EVENT 1 0.0000
984 HYPERSENSITIVITY 2 0.0000
985 CONTUSION 1 0.0000
986 PAIN IN EXTREMITY 3 0.0000
987 ABDOMINAL PAIN UPPER 2 0.0000
988 CONSTIPATION 2 0.0000
989 ASTHMA 1 0.0000
990 CHILLS 1 0.0000
991 PRURITUS 3 0.0000
992 ARTHRALGIA 3 0.0000
993 INJECTION SITE PAIN 2 0.0000
994 CONFUSIONAL STATE 1 0.0000
995 BACK PAIN 1 0.0000